Prosecution Insights
Last updated: October 27, 2026

University of Massachusetts: all pending office actions

← Back to University of Massachusetts

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19637632 CIRCULAR RNA VECTORS COMPRISING MODIFIED NUCLEOTIDES ABBOTT, KODYE LEE 1634 §102§103§112 Non-Final OA — Pending Apr 02, 2026
19568680 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS VANHORN, ABIGAIL LOUISE 1636 §103§112DP Non-Final OA — Pending Mar 16, 2026
19228243 PATTERNED NANOPARTICLE STRUCTURES POLLEY, CHRISTOPHER M 1785 Other Non-Final OA — Pending Jun 04, 2025
19217607 VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1) SALVOZA, M FRANCO G 1672 §112 Non-Final OA 57d Pending May 23, 2025
19102366 VACUUM-INSULATED STRUCTURES EMPLOYING PLANT MATERIALS, AND METHODS FOR FABRICATION AND USE THEREOF COLLISTER, ELIZABETH A 1784 §102§103 Non-Final OA — Pending Feb 07, 2025
18980456 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 1631 §112DP Non-Final OA 50d overdue Pending Dec 13, 2024
18869129 METHODS AND SYSTEMS FOR IMAGING INTERACTIONS BETWEEN PARTICLES AND FRAGMENTS NAH, JONGBONG 2674 §103 Non-Final OA — Pending Nov 25, 2024
18851628 ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER GRASER, JENNIFER E 1645 §103§112 Non-Final OA — Pending Sep 26, 2024
18807414 PATTERNING OF COMPLEX METAL OXIDE STRUCTURES VONCH, JEFFREY A 1781 §102§103 Non-Final OA — Pending Aug 16, 2024
18762831 METHOD FOR ELECTROCHEMICAL TREATMENT OF WATER MENDOZA, WILSON GALLARDO 1772 §103§112Other Non-Final OA — Pending Jul 03, 2024
18721049 FORMULATIONS FOR FORMING A STRUCTURED NANOPARTICLE COMPOSITE ROSWELL, JESSICA MARIE 1767 §102§103§112 Non-Final OA — Pending Jun 17, 2024
18743008 ACTIVATABLE NANOREPORTERS FOR REAL-TIME TRACKING OF MACROPHAGE PHENOTYPIC STATES ASSOCIATED WITH DISEASE PROGRESSION NOAKES, SUZANNE MARIE 1656 §102§112 Non-Final OA — Pending Jun 13, 2024
18719340 CONSTITUTIVE PRODUCTION OF MICROCINS TO TARGET ENTERIC BACTERIA RIGA, MICHAEL ANGELO 1634 §102§103§112 Non-Final OA — Pending Jun 13, 2024
18671475 ARTICLE COMPRISING NON-WELDABLE SUPERALLOYS AND METHODS OF MANUFACTURE THEREOF SULTANA, NAHIDA 1785 §102§112 Non-Final OA — Pending May 22, 2024
18660623 INTRAVENOUS POLE FOR IMPROVED SAFETY AND ACCURACY OF INTRAVENOUS MEDICATION ADMINISTRATION SOLOMON, JOSHUA BRENDON 3792 §103 Final Rejection — Pending May 10, 2024
18707207 WNT-MODULATING GENE SILENCERS AS BONE ANABOLIC THERAPY FOR OSTEOPOROSIS AND CRITICAL-SIZED BONE DEFECT VISONE, THOMAS J 1672 §103§112 Non-Final OA — Pending May 03, 2024
18706551 USES OF RHODOQUINONE FOR THE TREATMENT OF DISEASE BRAUN, MADELINE E 1624 §102§103§112 Non-Final OA — Pending May 01, 2024
18705007 A Subunit Cryptococcus Vaccine OGUNBIYI, OLUWATOSIN A 1645 §102§112 Non-Final OA — Pending Apr 26, 2024
18625271 HIGH THROUGHPUT LOCALIZED PASSIVE DIFFUSION DEVICE FOR PATTERNING ORGANOIDS ABBOTT, KODYE LEE 1634 §103 Non-Final OA — Pending Apr 03, 2024
18612111 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 1631 §103§112DP Non-Final OA — Pending Mar 21, 2024
18688729 AMPLIFIABLE METABOLIC LABELING FOR DETECTION OF BACTERIAL VIABILITY, GROWTH AND ANTIBIOTIC SUSCEPTIBILITY FAN, WEIHUA 1663 §103 Final Rejection 18d overdue Pending Mar 01, 2024
18582916 COMPACT MICRORING SCHEME FOR CHIP LASER INJECTION LOCKING AND OPTICAL PARAMETRIC OSCILLATION LEUNG, CHRISTINA Y 3991 §103§112Other Non-Final OA — Pending Feb 21, 2024
18439034 STABILIZATION OF OLIGONUCLEOTIDE AND OLIGONUCLEOTIDE-PROTEIN COMPLEX USING ALKYLATED PHOSPHATE MCINTOSH III, TRAVISS C 1693 §102§112 Non-Final OA — Pending Feb 12, 2024
18421647 MODIFIED OLIGONUCLEOTIDES TARGETING SNPs WHITEMAN, BRIAN A 1636 §102§103§112DP Non-Final OA — Pending Jan 24, 2024
18577623 MODULAR PRIME EDITING SYSTEMS FOR GENOME ENGINEERING WARD, AARON DUREL 1636 §102§112 Non-Final OA — Pending Jan 08, 2024
18396613 BRANCHED OLIGONUCLEOTIDES ZARA, JANE J 1635 §103§112DP Non-Final OA — Pending Dec 26, 2023
18561036 APPARATUS AND METHOD FOR CONTINUOUS PRODUCTION OF RNA MEYERING, SHABANA SHABBEER 1635 §103 Final Rejection — Pending Nov 15, 2023
18509212 Articles Formed From Fluorine-Containing Elastomer Compositions Using Additive Manufacturing Methods and Additive Manufacturing Methods for Thermoset Elastomer Compositions AHMED ALI, MOHAMED K 1743 §103 Non-Final OA — Pending Nov 14, 2023
18288786 ERGONOMIC SURGICAL INSTRUMENTS MENDEZ, KATHERINE H 3771 §102§103§112 Non-Final OA — Pending Oct 27, 2023
18288225 GENE THERAPIES FOR STARGARDT DISEASE (ABCA4) HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA — Pending Oct 25, 2023
18489422 ENCAPSULATING ELECTRONICS ON FLEXIBLE FLUOROELASTOMER SUBSTRATES CARLEY, JEFFREY T. 3729 §102§103 Final Rejection 13d Pending Oct 18, 2023
18380871 CONJUGATES OF SIRNA AND ANTISENSE OLIGONUCLEOTIDES (SIRNASO) AND METHODS OF USE IN GENE SILENCING POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112 Non-Final OA — Pending Oct 17, 2023
18287056 APPARATUS FOR ELECTROCHEMICAL AMMUNITION DISPOSAL AND MATERIAL RECOVERY CHUNG, HOSUNG CHARLES 1794 §103§112 Non-Final OA — Pending Oct 16, 2023
18482052 NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING MCKNIGHT, CIARA A 1656 §102§112 Non-Final OA — Pending Oct 06, 2023
18553600 Monomers and Polymers with Pendant Aspirin and Compositions and Methods Thereof FANG, SHANE 1766 §112 Non-Final OA — Pending Oct 02, 2023
18553357 Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons KONOPKA, CATHERINE ANNE 1635 §101§102§112 Non-Final OA — Pending Sep 29, 2023
18283675 ADIPOSE-DERIVED HYDROGEL COMPOSITIONS AND METHODS OF USE BERTOGLIO, VALARIE E 1632 §102§112 Final Rejection — Pending Sep 22, 2023
18279931 PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS REYNOLDS, FRED H 1658 §102§103 Final Rejection 57d Pending Sep 01, 2023
18213505 MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING KONOPKA, CATHERINE ANNE 1635 §103§112 Non-Final OA — Pending Jun 23, 2023
18208672 PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE ROGERS, JAMES WILLIAM 1618 §112 Final Rejection 12d Pending Jun 12, 2023
18255661 SYSTEM AND METHOD FOR HYDRODYNAMIC CULTIVATION OF SEED OXYGENIC PHOTOGRANULES VARMA, AKASH K 1773 §103 Final Rejection — Pending Jun 02, 2023
18141166 PROTECTING OLIGONUCLEOTIDES FOR CRISPR GUIDE RNA MEYERING, SHABANA SHABBEER 1635 §103§112Other Final Rejection — Pending Apr 28, 2023
18299947 REDOX FLOW BATTERY AKRAM, IMRAN 1725 §102§103§112Other Non-Final OA — Pending Apr 13, 2023
18247157 MARF/MFN MODULATORS AND USES THEREOF GROOMS, TIFFANY NICOLE 1637 §103§112 Non-Final OA 37d overdue Pending Mar 29, 2023
18120030 OLIGONUCLEOTIDES FOR APP MODULATION ALLEN, SARAH ELIZABETH 1637 §103§112 Final Rejection 2d overdue Pending Mar 10, 2023
18021901 DEVELOPMENT OF NOVEL GENE THERAPEUTICS FOR INFLAMMATION-INDUCED BONE LOSS SULLIVAN, STEPHANIE LAUREN 1635 §112 Non-Final OA 27d Pending Feb 17, 2023
18094695 OLIGONUCLEOTIDES FOR MECP2 MODULATION DACE DENITO, ALEXANDRA GERALDINE 1636 §103§112 Final Rejection 22d Pending Jan 09, 2023
18088544 POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY POPA, ILEANA 1633 §103Other Final Rejection 28d Pending Dec 24, 2022
18081604 NANODEVICES AND METHODS FOR MEASURING BIOFLUIDIC FLOW USING A GRAPHENE-BASED MICROELECTRODE MONTGOMERY, MELISSA JO 3791 §102§103§112 Non-Final OA 9d Pending Dec 14, 2022
18065255 SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES NICOL, ALEXANDER W 1634 §103§112 Non-Final OA 79d overdue Pending Dec 13, 2022
17983924 MULTILAYERED META LENS AND OPTICAL APPARATUS INCLUDING THE SAME SANZ, GABRIEL A 2872 §103 Non-Final OA 9d overdue Pending Nov 09, 2022
18053407 CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF LEONARD, ARTHUR S 1631 §103Other Final Rejection — Pending Nov 08, 2022
18049724 COMPLEXES FOR GENE DELETION AND EDITING LEONARD, ARTHUR S 1631 §103§112 Final Rejection 11d overdue Pending Oct 26, 2022
17913100 MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE WHITEMAN, BRIAN A 1636 §103 Non-Final OA 8d Pending Sep 20, 2022
17777386 COMPOSITIONS AND METHODS FOR ON-DEMAND RELEASE OF ANTIMICROBIAL AGENTS VANHORN, ABIGAIL LOUISE 1636 §103§112 Non-Final OA — Pending May 17, 2022
17777363 COMPOSITIONS AND METHODS FOR OPTOGENETIC IMMUNOTHERAPY HAMA, JOANNE 1647 §102§103 Non-Final OA 5d overdue Pending May 17, 2022
17730369 SYSTEM AND METHODS FOR EVALUATING IMAGES AND OTHER SUBJECTS BIBBEE, CHAYCE R 2624 §103 Non-Final OA — Pending Apr 27, 2022
17639962 ADENO-ASSOCIATED VIRUS VECTOR PLATFORM FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF SPENCER, ANDREA LYNNE MORRIS 1631 §103 Final Rejection 11d overdue Pending Mar 03, 2022
17635047 TARGETING OF THE CYTOSKELETON AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE DISEASE CONNORS, ALEXANDRA F 1634 §103 Final Rejection — Pending Feb 14, 2022
17608890 IRF2 AS A PROGNOSTIC BIOMARKER AND TARGET FOR AUGMENTING IMMUNOTHERAPY PATTERSON, SARAH COOPER 1675 §103§112 Final Rejection — Pending Nov 04, 2021
17604545 GENE THERAPIES FOR USHER SYNDROME (USH2A) WILSON, MICHAEL C 1638 §103§112 Final Rejection 40d Pending Oct 18, 2021
17601522 AIM2 INHIBITORS AND USES THEREOF TRAN, CHRISTINA L 1637 §103 Final Rejection 4d overdue Pending Oct 05, 2021
17439439 Therapeutic Targets for Oncogenic KRAS-Dependent Cancers GIBBS, TERRA C 1635 §103 Non-Final OA — Pending Sep 15, 2021
17235153 OLIGONUCLEOTIDES FOR MSH3 MODULATION VYAS, KEYUR ANILKUMAR 1637 §103 Non-Final OA 5d Pending Apr 20, 2021
17054791 RAAV VECTORS ENCODING OF LYSOSOMAL BETA-GALACTOSIDASE (GLB1) AND CATHEPSIN A EBBINGHAUS, BRIANA NOEL 1632 §112 Final Rejection 5d overdue Pending Nov 12, 2020
16999759 O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES ARIETI, RUTH SOPHIA 1635 §103DP Non-Final OA — Pending Aug 21, 2020
18728767 CELL CULTURE METHODS NGUYEN, NGHI V 1653 §102§112 Non-Final OA — Pending Jul 12, 2024
17186940 Lane-Level Route Planner for Autonomous Vehicles ALSOMAIRY, IBRAHIM ABDOALATIF 3667 §103 Final Rejection — Pending Feb 26, 2021

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month